Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
Login My Member Benefits Archives Research Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    ×
  • Subscribe
Enter stock ticker or keyword
×
5 Ways to Beat the Fed (and Crush Inflation)

Email this Article

Send with mail | ahoo instead.
Required Needs to be a valid email
Required Needs to be a valid email
TEVA - Money Morning
https://moneymorning.com/stocks/teva/
Required Please enter the correct value.
Twitter
TEVA

Teva Pharmaceutical Industries Ltd

Trading Strategies

The Best REIT to Buy Right Now Will Pay 8.5% Yield

January 25, 2022 by Tim Melvin

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Tim Melvin picks out the best REIT to buy right now.

I’m expecting another fantastic year for these easy-to-own investments and their often-attractive yields. And today I’m going to name one I think everyone should own for maximum upside…

Dow Jones

The Dow Jones Today Will Jump as China Approaches the Table

August 27, 2019 by Money Morning Staff Reports

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

The Dow Jones today will rise as the U.S. and China seem eager to reach a trade agreement.

Both countries have expressed optimism this week, in the lead-up to a new set of discussions.

Read more here...

Dow Jones

The Dow Jones Today Will Lose Hundreds of Points as China Raises Tariffs

May 13, 2019 by Garrett Baldwin

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

The Dow Jones today will plummet as China plans its own tariff hike on $60 billion of U.S. goods starting June 1.

This is the latest intensification of a trade war between the countries.

Read more here...

Dow Jones

Dow Jones Today Surges as Volatile Rally Continues into Fourth Straight Day

February 15, 2018 by Garrett Baldwin

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

The Dow Jones today is set to continue its push back towards record territory as investors re-enter the market after this month's correction.

While volatility remains high, we think there's plenty of profit potential in this market for the prepared investor...

Stocks

4 Stocks to Avoid at All Costs in 2018

December 22, 2017 by Money Morning Staff Reports

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Thanks to a late-day sell-off Thursday (Dec. 21), the Dow Jones Industrial Average just missed yet another record-high close.

Even so, this illustrious index has already logged an incredible 70 record-high closes in 2017, more than in any other year in its 122-year history.

But even with the market soaring in 2017, there are still some dogs that don't deserve any space in your portfolio. And we've pinpointed the four absolute worst stocks to avoid in 2018 for readers today...

Technology

These Four Stocks Are the Most Dangerous Dogs on Wall Street

December 6, 2017 by Michael A. Robinson

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Call it the "millennial market."

No, I'm not talking about how twenty- and thirtysomethings are affecting the market.

Instead, I'm talking about how we now measure the advance of the bellwether Dow Jones Industrial Average not by hundreds, but by thousands.

The Dow has advanced by 1,000 points five times this year… so far.

In fact, it took just 30 days for it to reach 24,000 on Nov. 30.

That's great news for just about every investor.

But the news is even better for investors like you. Here's why...

stocks

3 of the Top Pharmaceutical Stocks to Buy Now

August 4, 2017 by Money Morning News Team

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Our top pharmaceutical stocks to buy are all expected to have double-digit gains, making now a great time to buy.

With new drugs on the market, these companies have revenue coming in to fund pipeline developments. These pipeline developments will fuel revenue growth for years to come.

One of the stocks on our list is expected to gain as much as 172% in the next 12 months...

Stocks

3 Biotech Stocks to Buy Now for Up to 270% Growth

July 6, 2017 by Money Morning News Team

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Our expert has put together a set of biotech-buying guidelines to make finding the best biotech stocks to buy simple and profitable.

Using his guidelines, we've found three biotech stocks about to skyrocket.

One of them on our list could gain as much as 270% in the next 12 months...

Biotechnology

The 3 Best Pharmaceutical Stocks to Buy in 2017

June 6, 2017 by Ashley Moore

View Comments

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Our expert has developed a vetting process to identify the best pharmaceutical stocks to buy in 2017.

One of the stocks he picked using this set of guidelines is already up almost 60% year to date.

Here are the guidelines and the best stocks to buy now for major profits this year...

biotechnology

How Mylan Stole $1.27 Billion from Taxpayers and Rewarded Its Top Execs

June 1, 2017 by Casey Wilson

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Once again, a Big Pharma company has rewarded its top execs at the expense of shareholders…

Mylan overcharged the government (a.k.a. the taxpayers) for EpiPen distribution by over a billion dollars.

Here's how they did it...

First
  • 1
  • 2
NextLast
LIVE
Visit Money Morning Live
Latest News

January 19, 2023 • By Money Morning Stock Research Team

These Stocks Could Go To $0

January 9, 2023 • By Money Morning Stock Research Team

The Government Is Pouring $391 Billion Into These Stocks - Buy Now

December 27, 2022 • By Money Morning Staff Reports

6 IPOs in 2023 You Can’t Afford to Miss
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Profit Takeover This Is VWAP Penny Hawk Trading Today Midday Momentum Pump Up the Close
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Night Trader Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Extreme Profit Hunters Profit Revolution Warlock's World Penny Nation Quantum Data Profits Live Trading Alliance Trade The Close Inside Money Trader Expiration Trader Vega Burst Trader Flashpoint Trader Darknet Hyper Momentum Trader

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell My Info